politics

GSK to Reduce Workforce as Part of £1.9bn Cost-Cutting Strategy

28 Temmuz 2026The Guardian

GSK is implementing a £1.9bn cost-cutting plan that will involve significant job cuts while investing £400m in UK life sciences. The company will relocate over 1,000 scientists to a new research and development site in Cambridge, closing its current R&D facility in Stevenage by 2029.
This strategic move aims to accelerate drug development under the leadership of the new CEO.
The pharmaceutical sector is facing increasing pressure to reduce costs and improve the speed of drug development. GSK's restructuring is part of a larger industry trend aimed at enhancing competitiveness and responsiveness to market demands.
GSK's decision to cut jobs while simultaneously investing in a new R&D center reflects a broader trend in the pharmaceutical industry where companies are seeking to streamline operations for greater efficiency. The relocation of scientists to Cambridge could foster innovation, but the job losses raise concerns about…

NewsAI özeti

This summary is based on information from The Guardian and is intended for informational purposes only.